Oncology Drugs - Ukraine | Statista Market Forecast

The Oncology Drugs market in Ukraine is projected to reach a revenue of US$102.90m in 2024.
It is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 7.04%, which will lead to a market volume of US$144.60m by 2029.
When comparing globally, United States is expected to generate the highest revenue of US$103.90bn in 2024.
The demand for innovative oncology drugs is growing rapidly in Ukraine, as the country seeks to improve cancer treatment options for its population.

Definition:
The Oncology Drugs market covers drugs to treat cancer, including chemotherapy and immunotherapy. These therapies are used for solid tumors and hematologic cancer. The medications in this market are mainly physician-administered drugs.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Bristol-Myers Squibb, Roche, Merck & Co, Novartis, Johnson & Johnson

Treatment for different types of cancer, including skin cancer, leukemia, lymphoma, and multiple myeloma
Chemotherapeutic agents
Immuno-oncology drugs
Oncology orphan drugs

Radiation therapy
Medical devices

The Oncology Drugs market in Ukraine has been steadily growing in recent years.

Customer preferences: As in many other countries, the demand for oncology drugs in Ukraine has been increasing due to the rising incidence of cancer. Patients are also becoming more aware of the latest treatments available and are seeking out newer, more effective drugs. In addition, the aging population is also contributing to the growth of the market, as cancer is more prevalent in older people.

Trends in the market: One of the key trends in the Ukrainian Oncology Drugs market is the increasing use of immunotherapy. This is a relatively new treatment approach that harnesses the body's own immune system to fight cancer. Immunotherapy drugs have been shown to be effective in treating a range of cancers, including melanoma, lung cancer, and bladder cancer. As a result, they are becoming increasingly popular in Ukraine, with both patients and doctors opting for this treatment approach.Another trend in the market is the growing use of targeted therapies. These drugs are designed to target specific molecular or genetic abnormalities in cancer cells, which can help to improve treatment outcomes. Targeted therapies are particularly useful in cases where traditional chemotherapy is not effective. In Ukraine, there has been a significant increase in the use of targeted therapies in recent years, as doctors become more familiar with these drugs and their benefits.

Local special circumstances: One of the challenges facing the Ukrainian Oncology Drugs market is the high cost of these drugs. Many patients are unable to afford the latest treatments, which can be prohibitively expensive. This has led to a growing demand for more affordable alternatives, such as generic drugs. However, the quality of these drugs can vary, and there are concerns about the safety and efficacy of some generic products.

Underlying macroeconomic factors: The Ukrainian economy has been struggling in recent years, which has had an impact on the healthcare system. Funding for healthcare has been limited, which has made it difficult for hospitals and clinics to provide the latest treatments and drugs to patients. However, despite these challenges, the Oncology Drugs market in Ukraine has continued to grow, as patients and doctors seek out the best available treatments for cancer.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Cancer is one of the leading causes of death worldwide, with lung cancer alone ranked the sixth leading cause of death in 2021. Cancer, also known as malignant tumors and neoplasms, is the result of interactions between personal genetic factors and external agents causing abnormal transformations of cells into tumors over time. As the global population has increased in age, the incidence of new cancer cases has also risen, contributing to a higher number of deaths each year. In 2022, nearly 10 million deaths were caused by cancer worldwide- a number which is expected to reach over 15 million by 2040.